CDK 4 and 6 Inhibitor Drug Market by Application The CDK 4 and 6 Inhibitor Drug Market exhibits significant growth across various therapeutic applications, driven primarily by the increasing prevalence of hormone receptor-positive breast cancer. CDK 4 and 6 inhibitors are pivotal in the treatment of this subtype of breast […]
Recent News